Brexit: Response to Government update on medicines and medical products supply

Warwick Smith, Director General of the British Generic Manufacturers Association (BGMA), said: “We welcome the Government providing more information on its plans to ensure appropriate supplies of medicines are available to patients in light of a no-deal Brexit. We have been working with the authorities for many months to put these plans in place, and it is right that they are In more transparent on their plans in the interests of patients as well as the supply chain.

“While we welcome the Government’s efforts to help ensure that patients continue to receive their medicines in the case of a no deal Brexit, we are absolutely clear that the only way to ensure continued availability of medicines, and future launches, is to be part of European Union regulatory framework and single market. We must avoid different standards and any checks at the border otherwise there will be an inevitable impact on patient well-being.”